Analytical and diagnostic accuracy of "second generation" assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers

Journal of Clinical Pathology

Volumn 57, Issue 4, 2004, Pages 378-382

  Villalta, D ^b   Orunesu, E ^a   Tozzoli, R ^c   Montagna, P ^a   Pesce, G ^a   Bizzaro, N ^d   Bagnasco, M ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b Pordenone Hospital   (Italy)

^c Clinical Pathology Unit   (Italy)

^d Clinical Pathology Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOLIGAND; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TRACER;

ADULT; ANALYTIC METHOD; ANTIBODY DETECTION; ARTICLE; ASSAY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; MALE; RECEPTORS, THYROTROPIN; ROC CURVE; SENSITIVITY AND SPECIFICITY; THYROIDITIS, AUTOIMMUNE;

EID: 1842454820     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2003.012294     Document Type: Article

References (15)

1. Shewring G, Smith BR. An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) 1982;17:409-17.
2. Morgenthaler NG, Nagata A, Katayama S, et al. Detection of low titre TBII in patients with GD using recombinant human TSH receptor. Clin Endocrinol (Oxf) 2002;57:193-8.
3. Pedersen IB, Knudsen N, Perrild H, et al. TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison or two competitive binding assays. Clin Endocrinol (Oxf) 2001;55:381-90.
4. Giovanella L, Ceriani L, Garancini S. Evaluation of the 2nd generation radioreceptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1St generation and anti-thyroperoxidase antibodies (AbTPO). Q J Nucl Med 2001;45:115-19.
5. Gupta MK. Thyrotropin-receptor antibodies in thyroid diseases: advances in detection techniques and clinical applications. Clin Chim Acta 2000;293:1-29.
6. Ilicki A, Gamstedt A, Karlsson FA. Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. J Clin Endocrinol Metab 1992;74:1090-4.
7. Kawai K, Tamai H, Matsubayashi S, et al. A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs. Clin Endocrinol (Oxf) 1995;43:551-6.
8. Costagliola S, Morgenthaler NG, Hoermann R, et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 1999;84:90-7.
9. Zimmermann-Belsing T, Nygaard B, Rasmussen AK, et al. Use of the 2nd generation TRAK human assay did not improve prediction of relapse after antithyroid medical therapy of Graves' disease. Eur J Endocrinol 2002;146:173-7.
10. Massart C, Orgiazzi J, Maugendre D. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs. Clin Chim Acta 2001;304:39-47.
11. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000;21:168-99.
12. Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003;58:38-40.
13. Bland JW, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet 1986;1:307-310.
14. Maugendre D, Massart C. Clinical value of a new TSH binding inhibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clin Endocrinol (Oxf) 2001;54:89-96.
15. Vitti P, Rago T, Chiovato L, et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment. Thyroid 1997;7:369-75.